What is the primary action of PCSK9 inhibitors (e.g., Praluent or Repatha) in cholesterol control? They increase the breakdown of LDL in the bloodstream. They bind to LDL receptors, enhancing their degradation. They reduce the absorption of cholesterol in the gut. They block PCSK9, allowing more LDL receptors on cell surfaces. […]
OK
Okoth
Academic Expert · EssayPanel
Expert academic writer and education specialist helping students in the UK, USA, and Australia achieve their best results across all subjects.
Need help with your own assignment?
Our expert writers can help you apply everything you've just read — to your actual assignment, brief, and marking criteria.
Get Expert Help Now →